piracetam has been researched along with Motor Neuron Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Motor Neuron Disease: Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam was well tolerated." | 6.74 | Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009) |
| "Levetiracetam was well tolerated." | 2.74 | Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedlack, RS | 1 |
| Pastula, DM | 1 |
| Hawes, J | 1 |
| Heydt, D | 1 |
1 trial available for piracetam and Motor Neuron Disease
| Article | Year |
|---|---|
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
Topics: Adult; Aged; Anticonvulsants; Disease Progression; Humans; Levetiracetam; Middle Aged; Motor Neuron | 2009 |